IMR — Imricor Medical Systems Share News
0.000.00%
Last trade - 00:00- AU$512.72m
- AU$463.18m
- $0.29m
Brief: Imricor Medical Systems Says Northstar 3D Mapping System Got IDE Approval From US FDA
Brief: Imricor Medical Systems Says Visabl-Afl Trial For US FDA Approval Receives Ethics Approval
Australia's Imricor Medical jumps most in 1 month on clinical trial approval
Brief: Imricor Medical Systems Says Ethics Committee At Lausanne University Hospital Approved Visabl-Afl Clinical Trial
Brief: Imricor Medical Systems Says Diagnostic Catheter Receives CE Mark Approval To Sell Into Europe
Brief: Imricor Medical Systems Posts FY Net Loss Attributable To Members $22.6 Mln, Up 30.36%
Brief: Imricor Medical Systems Inc Says In Fy24, Imricor Will Strategically Leverage FDA Approval For The Visabl-Afl Trial
Brief: Imricor Medical Systems Announces Placements & Entitlement Offer To Raise Up To A$15 Mln
Brief: Imricor Medical Systems Seeks Trading Halt
Australia's Imricor Medical Systems rises on John Hopkins clinical trial approval
Brief: Imricor Medical Systems Announces Approval For Commencement Of Visabl-Afl Clinical Trial
Brief: Imricor Medical Systems Says Receives Approval From Saudi Food And Drug Authority
ASX-listed shares of Imricor Medical jump on marketing nod in Saudi Arabia
Brief: Imricor Medical Systems Expands Middle East Footprint Into Qatar
Australia's Imricor Medical rises on joint development deal
Brief: Imricor Medical Systems Announces Joint Development Agreement With ADIS For AI Modules
Australia's Imricor Medical Systems up on premium placement
Brief: Imricor Medical Systems Says Secures A$4.4 Mln Through Placement
Brief: Imricor Medical Systems Announces Request For Voluntary Suspension